Beurs gesloten -
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
5,56 EUR | -0,71% | +3,35% | +29,91% |
Omzet 2023 | 2,23 mln. 2,38 mln. | Omzet 2024 * | 37,83 mln. 40,45 mln. | Marktkapitalisatie | 120 mln. 128 mln. |
---|---|---|---|---|---|
Nettowinst (verlies) 2023 | -23 mln. -24,59 mln. | Nettowinst (verlies) 2024 * | -5 mln. -5,35 mln. | EV/omzet 2023 | 36,2 x |
Nettoschuld 2023 * | 33,7 mln. 36,04 mln. | Nettoschuld 2024 * | 46,6 mln. 49,83 mln. | EV/omzet 2024 * | 4,4 x |
K/w-verhouding 2023 |
-3,63
x | K/w-verhouding 2024 * |
-12,9
x | Werknemers | 62 |
Dividendrendement 2023 * |
-
| Dividendrendement 2024 * |
-
| Vrij verhandelbaar | 72,4% |
Recentste transcriptie over OSE Immunotherapeutics
1 dag | -0,71% | ||
1 week | +3,35% | ||
Lopende maand | +14,40% | ||
1 maand | +12,66% | ||
3 maanden | +41,30% | ||
6 maanden | +33,81% | ||
Lopend jaar | +29,91% |
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Founder | 69 | 17-11-04 | |
Nicolas Poirier
CEO | Chief Executive Officer | 42 | 31-05-16 |
Director of Finance/CFO | - | 01-05-16 |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Founder | 69 | 17-11-04 | |
Director/Board Member | 66 | 22-06-23 | |
Director/Board Member | 66 | 18-02-22 |
Datum | Koers | Variatie | Volume |
---|---|---|---|
26-04-24 | 5,56 | -0,71% | 87 408 |
25-04-24 | 5,6 | -0,71% | 158 909 |
24-04-24 | 5,64 | -5,53% | 240 936 |
23-04-24 | 5,97 | 0,00% | 376 959 |
22-04-24 | 5,97 | +10,97% | 410 921 |
Real Time Euronext Paris, 26 april 2024 om 17:35 uur
Meer koersenHerzieningen van WPA
Vaira. 1 jan. | Kapi. | |
---|---|---|
+29,91% | 128 mln. | |
+1,51% | 42,75 mld. | |
+8,57% | 41,34 mld. | |
+49,22% | 41,61 mld. | |
-12,36% | 26,59 mld. | |
+8,92% | 25,49 mld. | |
-25,13% | 18,12 mld. | |
+29,17% | 12,24 mld. | |
-3,12% | 11,76 mld. | |
+6,35% | 11 mld. |